CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)
5.970
+0.880
(+17.29%)
Streaming Delayed Price
Updated: 2:36 PM EDT, Aug 18, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 58,993 |
| Open | 5.310 |
| Bid (Size) | 5.910 (1) |
| Ask (Size) | 6.030 (6) |
| Prev. Close | 5.090 |
| Today's Range | 5.110 - 6.090 |
| 52wk Range | 4.930 - 221.94 |
| Shares Outstanding | 574,580 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
What Women Need to Know About Benign Brain Tumors
August 14, 2025
Study Reveals Potential Way to Treat Pediatric Gliomas
August 11, 2025
CNS Pharmaceuticals Announces Reverse Stock Split
July 18, 2025
Frequently Asked Questions
Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 5.970
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 08/18/25 02:36 PM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 3.43M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
